Gambling on Reproducibility

New research finds that observers placing bets in a stock exchange–like environment are pretty good at predicting the replicability of psychology studies.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Can science publishing benefit from the establishment of a stock exchange of sorts?WIKIMEDIA, NEW YORK STOCK EXCHANGEThe poor reproducibility dogging psychological science has been well documented in recent months. Now, an international team of researchers—some of whom were the first to sound the alarm regarding the field’s replication problems—suggests that solving the predicament may lie in setting up futures markets in which psychologists acting as traders place bets on whether or not a particular study’s findings will be replicated in future attempts.

“The results show that a collection of knowledgeable peers do have a good sense of what will replicate and what won’t,” Caltech behavioral economist Colin Camerer, who was not involved with the study, told Nature. “This information is in the judgments of peers but has never been collected and quantified until now.”

The study’s findings, published yesterday (November 9) in PNAS, further indicate that psychologists simply asked in isolation to predict which studies are likely to be successfully replicated perform no better than random chance would dictate. But add money and an ability to see where peers are placing their bets, and the quality of those predictions increases significantly. “There is some wisdom of crowds; people have some intuition about which results are true and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies